Literature DB >> 15951835

Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization.

Janine Antonov1, Darlene R Goldstein, Andrea Oberli, Anna Baltzer, Marco Pirotta, Achim Fleischmann, Hans J Altermatt, Rolf Jaggi.   

Abstract

Quantitative reverse transcriptase real-time PCR (QRT-PCR) is a robust method to quantitate RNA abundance. The procedure is highly sensitive and reproducible as long as the initial RNA is intact. However, breaks in the RNA due to chemical or enzymatic cleavage may reduce the number of RNA molecules that contain intact amplicons. As a consequence, the number of molecules available for amplification decreases. We determined the relation between RNA fragmentation and threshold values (Ct values) in subsequent QRT-PCR for four genes in an experimental model of intact and partially hydrolyzed RNA derived from a cell line and we describe the relation between RNA integrity, amplicon size and Ct values in this biologically homogenous system. We demonstrate that degradation-related shifts of Ct values can be compensated by calculating delta Ct values between test genes and the mean values of several control genes. These delta Ct values are less sensitive to fragmentation of the RNA and are unaffected by varying amounts of input RNA. The feasibility of the procedure was demonstrated by comparing Ct values from a larger panel of genes in intact and in partially degraded RNA. We compared Ct values from intact RNA derived from well-preserved tumor material and from fragmented RNA derived from formalin-fixed, paraffin-embedded (FFPE) samples of the same tumors. We demonstrate that the relative abundance of gene expression can be based on FFPE material even when the amount of RNA in the sample and the extent of fragmentation are not known.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951835     DOI: 10.1038/labinvest.3700303

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  80 in total

1.  Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.

Authors:  Hayato Fujita; Kenoki Ohuchida; Kazuhiro Mizumoto; Soichi Itaba; Tetsuhide Ito; Kohei Nakata; Jun Yu; Tadashi Kayashima; Ryota Souzaki; Tatsuro Tajiri; Tatsuya Manabe; Takao Ohtsuka; Masao Tanaka
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

2.  Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: preferential expression of somatostatin receptor subtype 3.

Authors:  A P Casarini; E M Pinto; R S Jallad; R R Giorgi; D Giannella-Neto; M D Bronstein
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

3.  High-throughput quantification of splicing isoforms.

Authors:  Jean-Philippe Brosseau; Jean-François Lucier; Elvy Lapointe; Mathieu Durand; Daniel Gendron; Julien Gervais-Bird; Karine Tremblay; Jean-Pierre Perreault; Sherif Abou Elela
Journal:  RNA       Date:  2009-12-28       Impact factor: 4.942

4.  Paraffin embedding contributes to RNA aggregation, reduced RNA yield, and low RNA quality.

Authors:  David L Evers; Junkun He; Yeon Ho Kim; Jeffrey T Mason; Timothy J O'Leary
Journal:  J Mol Diagn       Date:  2011-08-30       Impact factor: 5.568

5.  Global gene expression profiling of formalin-fixed paraffin-embedded tumor samples: a comparison to snap-frozen material using oligonucleotide microarrays.

Authors:  Matthias Frank; Claudia Döring; Dirk Metzler; Susan Eckerle; Martin-Leo Hansmann
Journal:  Virchows Arch       Date:  2007-05-04       Impact factor: 4.064

6.  Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.

Authors:  Dolly G Aguilera; Chandra M Das; Neeta D Sinnappah-Kang; Celine Joyce; Pete H Taylor; Sijin Wen; Martin Hasselblatt; Werner Paulus; Greg Fuller; Johannes E Wolff; Vidya Gopalakrishnan
Journal:  J Neurooncol       Date:  2009-01-16       Impact factor: 4.130

7.  Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells.

Authors:  Per O Iversen; Elvira Semaeva; Dag R Sorensen; Helge Wiig; Mouldy Sioud
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

8.  Copy-number analysis of topoisomerase and thymidylate synthase genes in frozen and FFPE DNAs of colorectal cancers.

Authors:  Jinsheng Yu; Ryan Miller; Wanghai Zhang; Mala Sharma; Vicky Holtschlag; Mark A Watson; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2008-10       Impact factor: 2.533

9.  Circadian gene expression predicts patient response to neoadjuvant chemoradiation therapy for rectal cancer.

Authors:  Haijie Lu; Qiqi Chu; Guojiang Xie; Hao Han; Zheng Chen; Benhua Xu; Zhicao Yue
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancer.

Authors:  Enrique Espinosa; Iker Sánchez-Navarro; Angelo Gámez-Pozo; Alvaro Pinto Marin; David Hardisson; Rosario Madero; Andrés Redondo; Pilar Zamora; Belén San José Valiente; Marta Mendiola; Manuel González Barón; Juan Angel Fresno Vara
Journal:  PLoS One       Date:  2009-06-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.